Brief: Bioarctic Says Eisai Simulates Leqembi Sales To Reach JPY 250-280 Bln In FY 2027
25/03/2025 07:09
March 25 (Reuters) - BioArctic AB BIOAb.ST: EISAI SIMULATES LEQEMBI SALES TO REACH JPY 250-280 BILLION IN FY 2027 Source text: ID:nWkrbXk66x Further company coverage: [BIOAb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million